Lexicon Pharmaceuticals, Inc.

RHUMBLINE ADVISERS LXRX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/11/2026

Shares

256,885

Value ($000)

617

Weight

0.0%

2019 Q4 - 2026 Q2 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/11/2026	617	0.0%	256,885	6/30/2026
2026 Q1	5/12/2026	0	0.0%	0	3/31/2026
2025 Q4	2/13/2026	0	0.0%	0	12/31/2025
2025 Q3	11/6/2025	0	0.0%	0	9/30/2025
2025 Q2	8/12/2025	0	0.0%	0	6/30/2025
2025 Q1	5/29/2025	63	0.0%	137,230	3/31/2025
2024 Q4	5/29/2025	113	0.0%	153,151	12/31/2024
2024 Q3	11/12/2024	229	0.0%	145,939	9/30/2024
2024 Q2	8/1/2024	257	0.0%	152,785	6/30/2024
2024 Q1	5/9/2024	324	0.0%	134,845	3/31/2024
2023 Q4	2/8/2024	199	0.0%	130,291	12/31/2023
2023 Q3	11/9/2023	142	0.0%	130,291	9/30/2023
2023 Q2	8/8/2023	320	0.0%	139,747	6/30/2023
2023 Q1	5/11/2023	304	0.0%	125,066	3/31/2023
2022 Q4	2/14/2023	228	0.0%	119,117	12/31/2022
2022 Q3	11/10/2022	272	0.0%	113,395	9/30/2022
2022 Q2	8/11/2022	181	0.0%	97,470	6/30/2022
2022 Q1	5/12/2022	167	0.0%	79,934	3/31/2022
2021 Q4	2/10/2022	341	0.0%	86,660	12/31/2021
2021 Q3	11/12/2021	404	0.0%	83,991	9/30/2021
2021 Q2	8/5/2021	375	0.0%	81,792	6/30/2021
2021 Q1	5/6/2021	323	0.0%	55,078	3/31/2021
2020 Q4	2/10/2021	194	0.0%	56,689	12/31/2020
2020 Q3	11/12/2020	72	0.0%	50,159	9/30/2020
2020 Q2	8/13/2020	129	0.0%	64,886	6/30/2020
2020 Q1	5/6/2020	110	0.0%	56,607	3/31/2020
2019 Q4	2/5/2020	249	0.0%	60,107	12/31/2019